Page 2 - Selecta Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities analysts expect that Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) will post $18.82 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Selecta Biosciences’ earnings. The lowest sales estimate is $18.00 million and the highest is $19.65 million. Selecta Biosciences reported sales of $11.05 million […]

Equities research analysts expect Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) to announce ($0.09) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Selecta Biosciences’ earnings. Selecta Biosciences posted earnings per share of ($0.22) in the same quarter last year, which suggests a positive year-over-year […]

Takeda halted two trials for a narcolepsy candidate to examine a safety signal. The Japanese pharma also signed a gene therapy pact potentially worth over $1 billion with Selecta Biosciences. Moderna has identified "human error" as the source of contaminations in its halted COVID-19 vaccine doses in Japan. And more.

Selecta Biosciences (NASDAQ:SELB) shares are tra...